February 11, 2021

COVID-19 Vaccine Update

Beginning today, Thursday, February 11th,  anyone accompanying Massachusetts residents over the age of 75 who are getting a COVID-19 vaccine may make an appointment to get vaccinated themselves at any of the state’s mass vaccination sites. Both individuals must have an appointment for the same day and only one companion is allowed. 


For more information:

December 17, 2020

Letter to Massachusetts General Hospital Memory Division Patients

Winter Holiday/Vaccine Letter to Patients – 16 December 2020


To: Massachusetts General Hospital Memory Division Patients


This holiday season, we need your continued help to stop the spread of COVID-19. We are committed to your health and ask that for your safety and the safety of our community, you please stay home during the holidays.  


This year, with COVID-19 rapidly increasing throughout our country, we all need a different winter holiday plan. While we would like to celebrate the winter holidays with family and friends, this year, we need to be extremely cautious and stay away from those outside our immediate household. Consider “seeing” family and friends over video feeds (i.e., Zoom or FaceTime) or similar technology, not in person. If you must be with people outside of your household, we recommend you stay  outdoors, distanced by at least 6 feet, masked at all times, and not eating together. If you remove your mask or others remove theirs, it puts you at very high risk for disease transmission. If you do intend to travel, be aware that it may be challenging to access healthcare. Visit the CDC website: for additional information about the holiday season. We can all do our part to slow the spread of COVID-19 and protect ourselves, our loved ones, and our communities.  


The holiday season, however, does bring good news. With the advent of several promising COVID-19 vaccines, we have good reason to be hopeful as we move into the new year. The Commonwealth of Massachusetts  has developed a phased approach for vaccine distribution schedule. You can learn more by visiting:


In addition, Massachusetts General Hospital will be posting the latest vaccination guidelines on our website,, and your Mass General care team will provide details on a vaccine distribution plan to eligible patients as soon as this information is available. 


In the meantime, please remember that it is very important that you continue to wear a mask when you are outside of your home, follow strict hand hygiene practices by washing your hands frequently with soap and water and using hand sanitizer, and please continue to practice social distancing. These guidelines will remain in place for some time even after receiving the COVID-19 vaccine. 


May you all have a healthy and safe holiday season. Our team is here for you.


Best regards and stay safe,


Dr. Teresa Gomez-Isla

Mass General Memory Division Chief/Department of Neurology


October 15, 2020

Call for Clinical Fellowship in Dementia at MGH 2022

The Massachusetts Alzheimer's Disease Research Center (MADRC) is pleased to announce an opening for a two-year Clinical Fellowship in Dementia at the Massachusetts General Hospital (MGH) and related institutions beginning July 1, 2022.

The goal of the non-degree program is to introduce exceptionally-qualified individuals to the successes and demands of a clinical career in dementia and related neurodegenerative diseases, and to provide an unparalleled foundation for potential leadership roles in academic medicine, industry or related fields.

More information is attached.

Fellowship application deadline:  July 1, 2021



September 22, 2020

Clarity AD Study

Are you having problems with your memory and thinking abilities or concerned about recent changes? Do you have a family history of Alzheimer’s disease (AD)? Have you recently received a diagnosis of AD? Consider participating in the Clarity AD clinical trial. This study will assess the safety, tolerability, and effectiveness of a new investigational medication to determine if it will stop or reduce the amount of amyloid in the brain (a protein that can build up in the brain of individuals with AD) and evaluate if it will stop or slow the progression of symptoms in individuals living with early Alzheimer’s disease. For more information click on the attached flyer.

August 20, 2020

Zoom Tutorial

If you are new to Zoom and having trouble figuring it out, check out this great "Zoom How To" lesson put together by our friends at Michigan ADRC! See attached document.


August 5, 2020

MADRC Staff Present at Alzheimer's Association International Conference

The virtual Alzheimer’s Association International Conference (AAIC) last week brought together thousands of researchers from across the globe to share their findings. We are proud of the many MADRC-affiliated staff who presented study results and theories that will help advance Alzheimer’s and related dementia research!
Attached is a list of presentations made by MADRC team members* at AAIC (*in red).


August 5, 2020

Dr. Brad Dickerson Named Professor of Neurology at Harvard Medical School

Congratulations to Dr. Brad Dickerson who was recently promoted to Professor of Neurology at Harvard Medical School! Dr. Dickerson is the MGH Tommy Rickles Endowed Chair in Primary Progressive Aphasia Research, Director of the Frontotemporal Disorders Unit, and Leader of the Alzheimer Center Imaging Core. He has been an NIH-funded investigator continuously for more than 17 years and has over 195 peer-reviewed publications.

To learn more about Dr. Dickerson’s work:

July 28, 2020

Dr. Yakeel Quiroz Receives Inge-Grundke-Iqbal Award

Dr. Yakeel T. Quiroz received the Inge-Grundke-Iqbal Award for Alzheimer’s Research at the Alzheimer's Association International Conference underway this week! This award is presented to the senior author of the most impactful study published in Alzheimer’s research during the two calendar years preceding AAIC.

Dr. Quiroz is an Associate Professor in the Departments of Psychiatry and Neurology at Massachusetts General Hospital, Harvard Medical School, Director of the MGH Familial Dementia Neuroimaging Lab, and Director of the Multicultural Alzheimer’s Prevention Program (MAPP). She received the award for her investigation into the role of APOE3 Christchurch (R136S) mutation in the resistance to autosomal dominant Alzheimer’s disease. Her research group recently identified a PSEN1 mutation carrier who did not develop mild cognitive impairment until three decades after the expected age of onset. Additionally, this individual was found to carry two copies of the APOE3 Christchurch mutation, and had unusually high brain amyloid levels and limited tau and neurodegenerative measurements.

Dr. Quiroz’s findings, “Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report,” were published in Nature Medicine in 2019, and provide important insights into the role of this APOE mutation in neurodegeneration and clinical onset of Alzheimer’s disease dementia.